Financial Ratios Maestros Electronics & Telecommunications Systems Limited
Stocks
METSL
INE318N01011
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 153.15 INR | -2.48% |
|
+3.06% | +16.07% |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 10.91 | 0.83 | 4.39 | 7.9 | 4.53 | |||||
Return on Total Capital | 22.74 | 1.93 | 7.69 | 11.87 | 7.08 | |||||
Return On Equity % | 30.52 | 5.68 | 12.38 | 17.6 | 13.37 | |||||
Return on Common Equity | 30.52 | 5.68 | 12.38 | 17.6 | 13.37 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 27.48 | 59.1 | 45.39 | 45.39 | 46.06 | |||||
SG&A Margin | 6.65 | 32.83 | 16.23 | 13.81 | 16.13 | |||||
EBITDA Margin % | 18.85 | 9.99 | 15.35 | 20.26 | 15.93 | |||||
EBITA Margin % | 18.09 | 6.67 | 13.77 | 18.9 | 14.58 | |||||
EBIT Margin % | 18.09 | 6.67 | 13.77 | 18.9 | 14.58 | |||||
Income From Continuing Operations Margin % | 11.86 | 11.17 | 12.11 | 14.83 | 15.14 | |||||
Net Income Margin % | 11.86 | 11.17 | 12.11 | 14.83 | 15.14 | |||||
Net Avail. For Common Margin % | 11.86 | 11.17 | 12.11 | 14.83 | 15.14 | |||||
Normalized Net Income Margin | 10.15 | 9.55 | 10.09 | 12.96 | 12.3 | |||||
Levered Free Cash Flow Margin | 62.16 | -81.51 | -42.21 | 8.82 | 11.88 | |||||
Unlevered Free Cash Flow Margin | 63.56 | -79.87 | -41.38 | 9.97 | 12.35 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.96 | 0.2 | 0.51 | 0.67 | 0.5 | |||||
Fixed Assets Turnover | 5.98 | 1.42 | 3.02 | 3.3 | 2.26 | |||||
Receivables Turnover (Average Receivables) | 6.18 | 0.93 | 2.26 | 2.58 | 3 | |||||
Inventory Turnover (Average Inventory) | 3.17 | 1.22 | 3.6 | 4.44 | 2.7 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.42 | 1.53 | 2.2 | 1.78 | 2.77 | |||||
Quick Ratio | 1.29 | 1.21 | 1.85 | 1.53 | 2.32 | |||||
Operating Cash Flow to Current Liabilities | 0.79 | -0.28 | -0.38 | 0.29 | 0.36 | |||||
Days Sales Outstanding (Average Receivables) | 59.07 | 393.93 | 161.79 | 141.67 | 121.48 | |||||
Days Outstanding Inventory (Average Inventory) | 115.32 | 298.42 | 101.3 | 82.48 | 135.33 | |||||
Average Days Payable Outstanding | 113.79 | 286.51 | 109.69 | 49.39 | 82.36 | |||||
Cash Conversion Cycle (Average Days) | 60.6 | 405.84 | 153.4 | 174.77 | 174.46 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 9.75 | 9.31 | 18.75 | 17.52 | 10.31 | |||||
Total Debt / Total Capital | 8.88 | 8.52 | 15.79 | 14.91 | 9.35 | |||||
LT Debt/Equity | 0.65 | 0.6 | 0.33 | 0.14 | 0.04 | |||||
Long-Term Debt / Total Capital | 0.59 | 0.55 | 0.27 | 0.12 | 0.04 | |||||
Total Liabilities / Total Assets | 62.83 | 58.29 | 39.62 | 46.7 | 40.92 | |||||
EBIT / Interest Expense | 8.08 | 2.53 | 10.42 | 10.23 | 19.54 | |||||
EBITDA / Interest Expense | 8.42 | 3.79 | 11.62 | 10.96 | 21.35 | |||||
(EBITDA - Capex) / Interest Expense | 8.2 | 2.12 | 8.29 | 4.61 | 7.05 | |||||
Total Debt / EBITDA | 0.23 | 1.87 | 1.27 | 0.79 | 0.78 | |||||
Net Debt / EBITDA | -3.43 | -20.02 | -3.55 | -2.62 | -6.46 | |||||
Total Debt / (EBITDA - Capex) | 0.24 | 3.35 | 1.78 | 1.89 | 2.37 | |||||
Net Debt / (EBITDA - Capex) | -3.52 | -35.83 | -4.97 | -6.24 | -19.57 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 250.94 | -76.42 | 119.36 | 35.33 | -13.21 | |||||
Gross Profit, 1 Yr. Growth % | 88.79 | -49.28 | 68.46 | 35.35 | -11.93 | |||||
EBITDA, 1 Yr. Growth % | 437.73 | -87.5 | 237.02 | 78.6 | -31.72 | |||||
EBITA, 1 Yr. Growth % | 607.27 | -91.3 | 352.69 | 85.8 | -33.07 | |||||
EBIT, 1 Yr. Growth % | 607.27 | -91.3 | 352.69 | 85.8 | -33.07 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 1.53K | -77.79 | 137.82 | 65.71 | -11.44 | |||||
Net Income, 1 Yr. Growth % | 1.53K | -77.79 | 137.82 | 65.71 | -11.44 | |||||
Normalized Net Income, 1 Yr. Growth % | 1.39K | -77.81 | 131.82 | 73.83 | -17.61 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 1.45K | -77.82 | 138.22 | 65.69 | -11.43 | |||||
Accounts Receivable, 1 Yr. Growth % | 298.7 | -4.5 | -14.44 | 56.31 | -77.64 | |||||
Inventory, 1 Yr. Growth % | -85.81 | 76.89 | -44.36 | 107.36 | 9.06 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -1.53 | -0.48 | 7.69 | 38.27 | 19.06 | |||||
Total Assets, 1 Yr. Growth % | 43.42 | -6.89 | -21.69 | 35.21 | 3.08 | |||||
Tangible Book Value, 1 Yr. Growth % | 40.47 | 4.5 | 13.35 | 18.5 | 12.89 | |||||
Common Equity, 1 Yr. Growth % | 40.47 | 4.5 | 13.35 | 19.38 | 14.24 | |||||
Cash From Operations, 1 Yr. Growth % | -881.07 | -130.59 | -32.31 | -225.95 | -21.61 | |||||
Capital Expenditures, 1 Yr. Growth % | -1.96 | 108.39 | 118.94 | 261.26 | -21.16 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -547.35 | -130.93 | 12.33 | -128.27 | 17.08 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -588.69 | -129.63 | 13.66 | -132.61 | 7.57 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 122.87 | -9.03 | -28.08 | 72.3 | 8.38 | |||||
Gross Profit, 2 Yr. CAGR % | 57.12 | -2.14 | -7.56 | 51 | 9.18 | |||||
EBITDA, 2 Yr. CAGR % | 243.91 | -18.02 | -35.1 | 145.34 | 10.4 | |||||
EBITA, 2 Yr. CAGR % | 440.6 | -21.58 | -37.26 | 190.02 | 11.52 | |||||
EBIT, 2 Yr. CAGR % | 440.6 | -21.58 | -37.26 | 190.02 | 11.52 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 304.7 | 90.08 | -27.32 | 98.52 | 21.14 | |||||
Net Income, 2 Yr. CAGR % | 304.7 | 90.08 | -27.32 | 98.52 | 21.14 | |||||
Normalized Net Income, 2 Yr. CAGR % | 305.81 | 81.64 | -28.28 | 100.74 | 19.67 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 283.3 | 85.25 | -27.32 | 98.67 | 21.14 | |||||
Accounts Receivable, 2 Yr. CAGR % | 109.71 | 95.13 | -9.61 | 15.65 | -40.88 | |||||
Inventory, 2 Yr. CAGR % | 3 | -49.89 | -0.79 | 7.41 | 50.38 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -2 | -1.01 | 3.53 | 22.03 | 28.31 | |||||
Total Assets, 2 Yr. CAGR % | 62.18 | 15.56 | -14.61 | 2.9 | 18.06 | |||||
Tangible Book Value, 2 Yr. CAGR % | 22.69 | 21.16 | 8.83 | 15.89 | 15.66 | |||||
Common Equity, 2 Yr. CAGR % | 22.66 | 21.16 | 8.83 | 16.32 | 16.78 | |||||
Cash From Operations, 2 Yr. CAGR % | 469.24 | 54.58 | -54.5 | -7.47 | -0.64 | |||||
Capital Expenditures, 2 Yr. CAGR % | -37.08 | 42.94 | 113.6 | 181.24 | 68.77 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 306.32 | 17.62 | -40.73 | -43.65 | -42.5 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 329.54 | 20.34 | -41.96 | -39.12 | -40.8 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 72.81 | 5.41 | 21.99 | -11.21 | 37.09 | |||||
Gross Profit, 3 Yr. CAGR % | 41.52 | 7.78 | 17.28 | 4.97 | 26.16 | |||||
EBITDA, 3 Yr. CAGR % | 577.98 | 13.92 | 31.33 | -9.05 | 60.15 | |||||
EBITA, 3 Yr. CAGR % | 187.8 | 36.46 | 40.68 | -9.9 | 77.9 | |||||
EBIT, 3 Yr. CAGR % | 174.69 | 36.46 | 40.68 | -9.9 | 77.9 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 181.07 | 53.8 | 104.82 | -4.34 | 51.69 | |||||
Net Income, 3 Yr. CAGR % | 181.07 | 53.8 | 104.82 | -4.34 | 51.69 | |||||
Normalized Net Income, 3 Yr. CAGR % | 237.28 | 54.03 | 97.02 | -3.66 | 49.18 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 166.63 | 48.25 | 101.45 | -4.34 | 51.77 | |||||
Accounts Receivable, 3 Yr. CAGR % | 74.73 | 61.34 | 48.24 | 8.5 | -33.13 | |||||
Inventory, 3 Yr. CAGR % | 8.02 | 23.35 | -48.11 | 26.84 | 7.96 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -0.62 | -1.5 | 1.81 | 14.01 | 21.03 | |||||
Total Assets, 3 Yr. CAGR % | 39.17 | 34.79 | 1.5 | -0.47 | 2.96 | |||||
Tangible Book Value, 3 Yr. CAGR % | 18.72 | 16.3 | 18.5 | 11.96 | 14.88 | |||||
Common Equity, 3 Yr. CAGR % | 18.58 | 16.28 | 18.5 | 12.24 | 15.62 | |||||
Cash From Operations, 3 Yr. CAGR % | 143.9 | 114.82 | 17.38 | -36.02 | -12.45 | |||||
Capital Expenditures, 3 Yr. CAGR % | - | -6.21 | 64.77 | 154.49 | 84.06 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 368.53 | 72.19 | 16.26 | -53.69 | -28.12 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 309.48 | 76.17 | 18.07 | -52.11 | -26.42 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 33.92 | -2.69 | 21.7 | 28.31 | 16.35 | |||||
Gross Profit, 5 Yr. CAGR % | 23.39 | 1.21 | 19.35 | 23.34 | 13.97 | |||||
EBITDA, 5 Yr. CAGR % | 57.11 | -5.74 | 165.24 | 54.83 | 22.52 | |||||
EBITA, 5 Yr. CAGR % | 97.48 | -4.92 | 56.48 | 84.49 | 28.2 | |||||
EBIT, 5 Yr. CAGR % | 97.48 | -3.81 | 52.17 | 84.49 | 28.2 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 66.18 | 12.24 | 63.63 | 70.33 | 66.01 | |||||
Net Income, 5 Yr. CAGR % | 66.18 | 12.24 | 63.63 | 70.33 | 66.01 | |||||
Normalized Net Income, 5 Yr. CAGR % | 64.4 | 10.79 | 81.58 | 71.25 | 61.4 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 56.51 | 6.85 | 58.53 | 66.67 | 64.37 | |||||
Accounts Receivable, 5 Yr. CAGR % | 30.89 | 28.07 | 34.24 | 41.22 | 2.63 | |||||
Inventory, 5 Yr. CAGR % | 35.28 | 26.06 | 4.41 | 16.71 | -20.58 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -1.61 | -1.19 | 1.02 | 7.31 | 11.68 | |||||
Total Assets, 5 Yr. CAGR % | 22.76 | 19.58 | 14.47 | 20.99 | 7.83 | |||||
Tangible Book Value, 5 Yr. CAGR % | 13.98 | 12.96 | 14.66 | 16.14 | 17.35 | |||||
Common Equity, 5 Yr. CAGR % | 13.67 | 12.78 | 14.58 | 16.3 | 17.81 | |||||
Cash From Operations, 5 Yr. CAGR % | 94.25 | 43.47 | 24.61 | 53.37 | 9.91 | |||||
Capital Expenditures, 5 Yr. CAGR % | -31.9 | 5.4 | - | 45.52 | 66.36 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 209.4 | 35.32 | 104.91 | 10.39 | -12.27 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 160.42 | 37.26 | 87.42 | 15.17 | -10.42 |
Select your edition
All financial news and data tailored to specific country editions
















